IL201907A0 - Elimination of interference in immunoassays caused by anti-carbohydrate antibodies - Google Patents

Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Info

Publication number
IL201907A0
IL201907A0 IL201907A IL20190709A IL201907A0 IL 201907 A0 IL201907 A0 IL 201907A0 IL 201907 A IL201907 A IL 201907A IL 20190709 A IL20190709 A IL 20190709A IL 201907 A0 IL201907 A0 IL 201907A0
Authority
IL
Israel
Prior art keywords
immunoassays
elimination
interference
caused
carbohydrate antibodies
Prior art date
Application number
IL201907A
Other languages
English (en)
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of IL201907A0 publication Critical patent/IL201907A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL201907A 2007-05-07 2009-11-03 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies IL201907A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92814407P 2007-05-07 2007-05-07
US92843807P 2007-05-08 2007-05-08
PCT/US2008/062739 WO2008137885A1 (en) 2007-05-07 2008-05-06 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Publications (1)

Publication Number Publication Date
IL201907A0 true IL201907A0 (en) 2010-06-16

Family

ID=39666131

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201907A IL201907A0 (en) 2007-05-07 2009-11-03 Elimination of interference in immunoassays caused by anti-carbohydrate antibodies

Country Status (11)

Country Link
EP (1) EP2142925A1 (es)
JP (1) JP2010527005A (es)
KR (1) KR20100029083A (es)
CN (1) CN101680880A (es)
AU (1) AU2008247352A1 (es)
BR (1) BRPI0811290A2 (es)
CA (1) CA2686206A1 (es)
IL (1) IL201907A0 (es)
MX (2) MX2009012044A (es)
RU (1) RU2009141159A (es)
WO (1) WO2008137885A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548533T3 (es) 2010-04-29 2015-10-19 Theradiag Sa Procedimientos para detectar anticuerpos contra un fármaco
US9759732B2 (en) * 2014-02-11 2017-09-12 Genzyme Corporation Assays for detecting the presence or amount of an anti-drug antibody
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
GB201522839D0 (en) * 2015-12-23 2016-02-03 Randox Lab Ltd And Randox Teoranta Method
WO2017220645A1 (en) * 2016-06-23 2017-12-28 Ablynx N.V. Improved pharmacokinetic assays for immunoglobulin single variable domains
CN108535490A (zh) * 2017-03-06 2018-09-14 苏州和锐生物科技有限公司 生物制剂血药浓度检测方法及试剂
US12055551B2 (en) * 2018-07-10 2024-08-06 Regeneron Pharmaceuticals, Inc. Methods for mitigating drug target interference in an anti-drug antibody (ADA) immunoassay
CN113514632B (zh) * 2021-04-20 2024-06-25 中国科学技术大学 基于纳米抗体的微悬臂梁免疫传感方法
WO2023204378A1 (ko) * 2022-04-19 2023-10-26 의료법인 성광의료재단 혈액 내 항-약물항체 농도 측정을 통한 생물학적 약물에 대한 치료 반응성 예측 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705353A (en) * 1995-06-07 1998-01-06 Beckman Instruments, Inc. Method of reducing interferences in assays
US5856106A (en) * 1995-11-01 1999-01-05 Biotransplant, Inc. Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies

Also Published As

Publication number Publication date
RU2009141159A (ru) 2011-06-20
AU2008247352A1 (en) 2008-11-13
WO2008137885A1 (en) 2008-11-13
CN101680880A (zh) 2010-03-24
JP2010527005A (ja) 2010-08-05
KR20100029083A (ko) 2010-03-15
BRPI0811290A2 (pt) 2014-10-21
MX2009012044A (es) 2009-11-18
MX2009012048A (es) 2010-02-24
CA2686206A1 (en) 2008-11-13
EP2142925A1 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
HRP20181616T1 (hr) Potpuno ljudska anti-vap-1 monoklonska antitijela
IL201907A0 (en) Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
AP3371A (en) Anti-IGF antibodies
EP2331579A4 (en) MONOCLONAL ANTIBODIES
SG10201601279SA (en) Monoclonal Antibody STRO-4
IL218724A0 (en) Endoglin antibodies
HK1138790A1 (en) Anti-sclerostin antibodies
PL2195026T3 (pl) Przeciwciała przeciw sklerostynie
GB0708002D0 (en) Antibodies
IL200168A0 (en) Monoclonal anti-cxcl13 antibodies
IL201983A (en) Antibody against pan nrpa
EP2222871A4 (en) METHODS OF PERFORMING ULTRA-SENSITIVE IMMUNOASSAY
GB0718737D0 (en) Antibodies
PL2184605T3 (pl) Immunologiczny test podwójnego wiązania do detekcji przeciwciał
IL212900A0 (en) Isoform specific anti-her4 antibodies
HK1158977A1 (zh) 抗膜鐵轉運蛋白 單克隆抗體及其用途
ZA200907833B (en) Elimination of interference in immunoassays caused by anti-carbohydrate antibodies
GB0724185D0 (en) Antibodies